310823285 | MMC | 21079329 | | 9585961 | 9/6/2003 12:00:00 AM | Coronary Artery Disease . 
| | DIS | Admission Date : 9/27/2003 Report Status : Discharge Date : 4/26/2003 ****** DISCHARGE ORDERS ****** HOBOCK , HIRAM A. 810-04-78-4 Clasonnain Fre Service : CAR DISCHARGE PATIENT ON : 6/5/03 AT 11:00 AM CONTINGENT UPON Not Applicable WILL D/C ORDER BE USED AS THE D/C SUMMARY : YES Attending : PERONE , LEN DON , M.D. CODE STATUS : Full code DISPOSITION : Home DISCHARGE MEDICATIONS : ACYCLOVIR 400 MG PO BID ECASA -LRB- ASPIRIN ENTERIC COATED -RRB- 325 MG PO QD Override Notice : Override added on 11/25/03 by MCBRIEN , BENEDICT , M.D. on order for COUMADIN PO -LRB- ref # 47453166 -RRB- POTENTIALLY SERIOUS INTERACTION : ASPIRIN & WARFARIN Reason for override : aware DIGOXIN 0.375 MG PO QD FOLATE -LRB- FOLIC ACID -RRB- 1 MG PO QD LASIX -LRB- FUROSEMIDE -RRB- 40 MG PO QD Alert overridden : Override added on 11/25/03 by FOUTCH , HOWARD , M.D. POTENTIALLY SERIOUS INTERACTION : DILTIAZEM HCL & FUROSEMIDE Reason for override : aware NPH HUMULIN INSULIN -LRB- INSULIN NPH HUMAN -RRB- 75 UNITS qam ; 55 UNITS qpm SC 75 UNITS qam 55 UNITS qpm MVI THERAPEUTIC W/MINERALS -LRB- THERAP VITS/MINERALS -RRB- 1 TAB PO QD Alert overridden : Override added on 11/25/03 by HEINEKEN , WARNER , M.D. POTENTIALLY SERIOUS INTERACTION : SIMVASTATIN & NIACIN , VIT . 
B-3 Reason for override : aware COUMADIN -LRB- WARFARIN SODIUM -RRB- 5 MG PO QHS Food/Drug Interaction Instruction No high Vitamin-K containing foods Override Notice : Override added on 11/25/03 by DRONEY , PHILIP , M.D. on order for ZOCOR PO -LRB- ref # 62198790 -RRB- POTENTIALLY SERIOUS INTERACTION : WARFARIN & SIMVASTATIN Reason for override : aware Previous override information : Override added on 11/25/03 by SABO , JAYSON , M.D. on order for BACTRIM DS PO -LRB- ref # 89837063 -RRB- SERIOUS INTERACTION : WARFARIN & SULFAMETHOXAZOLE Reason for override : aware Previous override information : Override added on 11/25/03 by GOURLEY , DAVID , M.D. POTENTIALLY SERIOUS INTERACTION : ASPIRIN & WARFARIN Reason for override : aware ZOCOR -LRB- SIMVASTATIN -RRB- 20 MG PO QHS Food/Drug Interaction Instruction Avoid grapefruit unless MD instructs otherwise . 
Override Notice : Override added on 11/25/03 by BASALDUA , CHAS , M.D. on order for MVI THERAPEUTIC W/MINERALS PO -LRB- ref # 90713039 -RRB- POTENTIALLY SERIOUS INTERACTION : SIMVASTATIN & NIACIN , VIT . 
B-3 Reason for override : aware Previous override information : Override added on 11/25/03 by FARALDO , TOMMY , M.D. POTENTIALLY SERIOUS INTERACTION : WARFARIN & SIMVASTATIN Reason for override : aware TESSALON PEARLS -LRB- BENZONATATE -RRB- 100 MG PO TID Number of Doses Required -LRB- approximate -RRB- : 3 BACTRIM DS -LRB- TRIMETHOPRIM / SULFAMETHOXAZOLE DO ... -RRB- 1 TAB PO qMWF Alert overridden : Override added on 11/25/03 by SWINSON , RAYMUNDO , M.D. SERIOUS INTERACTION : WARFARIN & SULFAMETHOXAZOLE Reason for override : aware DILTIAZEM EXTENDED RELEASE 180 MG PO QD HOLD IF : SBP < 80 Food/Drug Interaction Instruction Avoid grapefruit unless MD instructs otherwise . 
Override Notice : Override added on 11/25/03 by KEKIWI , LEIF , M.D. on order for LASIX PO -LRB- ref # 74229880 -RRB- POTENTIALLY SERIOUS INTERACTION : DILTIAZEM HCL & FUROSEMIDE Reason for override : aware LOSARTAN 50 MG PO QD Number of Doses Required -LRB- approximate -RRB- : 1 ESOMEPRAZOLE 20 MG PO QD MAGNESIUM OXIDE -LRB- 241 MG ELEMENTAL MG -RRB- 400 MG PO BID DIET : House / Low chol/low sat . 
fat ACTIVITY : Walking as tolerated FOLLOW UP APPOINTMENT -LRB- S -RRB- : Dr. Coombes , WC , Dr. Altmark , ECHO scheduled , Arrange INR to be drawn on 5/17/02 with f/u INR 's to be drawn every 7 days . 
INR 's will be followed by PCP ALLERGY : Penicillins ADMIT DIAGNOSIS : Cardiomyopathy PRINCIPAL DISCHARGE DIAGNOSIS ; Responsible After Study for Causing Admission -RRB- Coronary Artery Disease . 
OTHER DIAGNOSIS ; Conditions , Infections , Complications , affecting Treatment/Stay Hodgkins Dx AAA repair 1994 Exertional CP-epigastric 1997 : mediast recur of HD CVPP x1 velban , araC , cisplt x3 VP16 , vinblast , dex , cisplat 3/19 Afib/flutter h/o CHF from adria OPERATIONS AND PROCEDURES : Cardiac Cath with Angiography . 
OTHER TREATMENTS/PROCEDURES -LRB- NOT IN O.R. -RRB- none . 
BRIEF RESUME OF HOSPITAL COURSE : 54y M with h/o recurrent Hodgkin 's Dz , s/p multiple chemo/xrt and s/p auto-BMT 11/25 , Cardiomyopathy -LRB- EF 50 % , mod MR -RRB- uncertain etiology admitted for elective R/L heart cath with angiography . 
Stress echo -LRB- 8/24 -RRB- negative for ischemia , ECG sugg . 
possible old inferoseptal infarct . 
PMH -- Hodgkin 's disease ; CMP ; AAA s/p repair ; claudication ; IDT2DM ; Atrial Fib . 
Meds -- Losartan , Coumadin , Diltiazem ER ; Nexium ; NPH ; Humalog CZI ; Folate ; Digoxin ; Bactrim MWF ; Acyclovir BID ; Lasix 40 ; MagOxide . 
PE -- JVP flat , no carotid bruit . 
IRIR , 1/6 SM , no gallop ; few crackles R base ; WWP . 
Cath -- Elevated filling pressures -LRB- RA 15-18 ; PCW 15-20 ; RVP 60/20 ; PA mean 35 ; CI = 1.6 Coronary -- LMain Nl ; LAD-90 % prox , 80-90 % mid , 60 % distal ; D1-80 % ; LCx diffuse 50 % ; RCA-subtotal occlusion -LRB- R dom anatomy -RRB- . 
HOSPITAL COURSE : 1 . 
CV -- Routine post cath care . 
Increase Dilt to 180 QD to maximize rate control . 
Given 3VD in setting of DM , consulted surgery re elective revascularization . 
2 -RRB- A/C : Heparin , bridge to Coumadin -LRB- reduce standing dose to 5qd -RRB- . 
3 -RRB- Onc/ID : Cont Bactrim/Acyclovir prophylaxis . 
ADDITIONAL COMMENTS : Take all medicines as directed -- note the new doses of Diltiazem -LRB- 180mg -RRB- and Coumadin -LRB- now just one 5mg tab every night -RRB- . 
In the event of chest pain , sweatiness , worsening shortness of breath , nausea , or any other concerns , call your doctor or return to the emergency room immediately . 
DISCHARGE CONDITION : Stable TO DO/PLAN : PFT 's , Echocardiogram as outpatient . 
No dictated summary ENTERED BY : YUEN , ARTURO , M.D. -LRB- XN21 -RRB- 6/5/03 @ 10 ****** END OF DISCHARGE ORDERS ****** 
